Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs ("Regulus"), today announced that Jay...

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from a real-world evidence study demonstrating high levels of fatigue and impacts on patients' lives in the areas...

Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today announced that new data evaluating the oral investigational agent dubermatinib (TP-0903), an AXL kinase...

Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced the presentation of expanded interim results from the VISIONARY-MS Phase 2 study in stable relapsing multiple...

Planet Fitness, Inc. (NYSE: PLNT), one of the largest and fastest-growing global franchisors and operators of fitness centers with more members than any other fitness brand, announced today its...